Biolase BIOL reported its Q4 earnings results on Thursday, March 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Biolase beat estimated earnings by 31.0%, reporting an EPS of $-1.76 versus an estimate of $-2.55.
Revenue was down $561 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $2.04 which was followed by a 20.0% drop in the share price the next day.
Here's a look at Biolase's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -1.85 | -5.33 | -20 | -64 |
EPS Actual | -3.89 | -4.24 | -18 | -128 |
Revenue Estimate | 13.96M | 15.36M | 10.18M | 14.07M |
Revenue Actual | 10.92M | 14.29M | 10.47M | 14.05M |
To track all earnings releases for Biolase visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.